Innate Pharma SA (IPHA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.43, -3.38% vs the prior close of $1.48.
- Volume 8.03K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
IPHA slides 3.4% to $1.43. Closed at $1.43, -3.38% vs the prior close of $1.48. Day range $1.43β$1.53, opened at $1.53.
IPHA daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β IPHA slides 3.4% to $1.43
- Closed at $1.43, -3.38% vs the prior close of $1.48. Day range $1.43β$1.53, opened at $1.53.
- Volume was 8.03K shares, 0.0x its 50-day average of 199.89K β lighter than usual.
- Price is -24.8% vs its 50-day average ($1.90) and -17.2% vs its 200-day average ($1.73).
- 52-week range $1.17β$2.71; today's close sits at 17% of that range, 47.2% below the 52-week high.
Oct 15, 2026 β IPHA jumps 3.5% to $1.48
- Closed at $1.48, +3.50% vs the prior close of $1.43. Day range $1.46β$1.58, opened at $1.47.
- Volume was 7.20K shares, 0.0x its 50-day average of 199.78K β lighter than usual.
- Price is -22.5% vs its 50-day average ($1.91) and -14.4% vs its 200-day average ($1.73).
- 52-week range $1.17β$2.71; today's close sits at 20% of that range, 45.4% below the 52-week high.
Oct 14, 2026 β IPHA dips 2.7% to $1.43, a 3-month low, 3 down days in a row
- Closed at $1.43, -2.72% vs the prior close of $1.47. Day range $1.42β$1.47, opened at $1.44.
- Volume was 9.30K shares, 0.0x its 50-day average of 199.64K β lighter than usual.
- Price is -25.3% vs its 50-day average ($1.91) and -17.3% vs its 200-day average ($1.73).
- 52-week range $1.17β$2.71; today's close sits at 17% of that range, 47.2% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 β IPHA dips 0.7% to $1.47, a 3-month low
- Closed at $1.47, -0.68% vs the prior close of $1.48. Day range $1.45β$1.48, opened at $1.47.
- Volume was 5.60K shares, 0.0x its 50-day average of 200.47K β lighter than usual.
- Price is -23.5% vs its 50-day average ($1.92) and -15.1% vs its 200-day average ($1.73).
- 52-week range $1.17β$2.71; today's close sits at 19% of that range, 45.8% below the 52-week high.
Oct 12, 2026 β IPHA slides 8.6% to $1.48
- Closed at $1.48, -8.64% vs the prior close of $1.62. Day range $1.46β$1.53, opened at $1.48.
- Volume was 33.80K shares, 0.2x its 50-day average of 199.98K β lighter than usual.
- Price is -23.2% vs its 50-day average ($1.93) and -14.6% vs its 200-day average ($1.73).
- 52-week range $1.17β$2.71; today's close sits at 20% of that range, 45.4% below the 52-week high.
Oct 9, 2026 β IPHA jumps 9.5% to $1.62
- Closed at $1.62, +9.46% vs the prior close of $1.48. Day range $1.49β$1.68, opened at $1.49.
- Volume was 46.90K shares, 0.2x its 50-day average of 199.51K β lighter than usual.
- Price is -16.1% vs its 50-day average ($1.93) and -6.6% vs its 200-day average ($1.73).
- 52-week range $1.17β$2.71; today's close sits at 29% of that range, 40.2% below the 52-week high.
Oct 8, 2026 β IPHA dips 2.6% to $1.48, a 3-month low
- Closed at $1.48, -2.63% vs the prior close of $1.52. Day range $1.47β$1.54, opened at $1.50.
- Volume was 18.40K shares, 0.1x its 50-day average of 199.17K β lighter than usual.
- Price is -23.5% vs its 50-day average ($1.93) and -14.7% vs its 200-day average ($1.73).
- 52-week range $1.17β$2.71; today's close sits at 20% of that range, 45.4% below the 52-week high.
Oct 7, 2026 β IPHA slides 4.4% to $1.52, a 3-month low
- Closed at $1.52, -4.40% vs the prior close of $1.59. Day range $1.50β$1.55, opened at $1.54.
- Volume was 13.80K shares, 0.1x its 50-day average of 198.99K β lighter than usual.
- Price is -21.7% vs its 50-day average ($1.94) and -12.4% vs its 200-day average ($1.74).
- 52-week range $1.17β$2.71; today's close sits at 23% of that range, 43.9% below the 52-week high.
Oct 6, 2026 β IPHA rises 0.6% to $1.59
- Closed at $1.59, +0.63% vs the prior close of $1.58. Day range $1.53β$1.65, opened at $1.58.
- Volume was 133.70K shares, 0.7x its 50-day average of 196.37K.
- Price is -18.2% vs its 50-day average ($1.94) and -8.5% vs its 200-day average ($1.74).
- 52-week range $1.17β$2.71; today's close sits at 27% of that range, 41.3% below the 52-week high.
Oct 5, 2026 β IPHA rises 1.3% to $1.58
- Closed at $1.58, +1.28% vs the prior close of $1.56. Day range $1.53β$1.69, opened at $1.54.
- Volume was 106.90K shares, 0.6x its 50-day average of 194.28K β lighter than usual.
- Price is -18.9% vs its 50-day average ($1.95) and -9.1% vs its 200-day average ($1.74).
- 52-week range $1.17β$2.71; today's close sits at 27% of that range, 41.7% below the 52-week high.
Oct 2, 2026 β IPHA dips 1.9% to $1.56, a 3-month low
- Closed at $1.56, -1.89% vs the prior close of $1.59. Day range $1.53β$1.69, opened at $1.56.
- Volume was 92.70K shares, 0.5x its 50-day average of 192.52K β lighter than usual.
- Price is -20.1% vs its 50-day average ($1.95) and -10.3% vs its 200-day average ($1.74).
- 52-week range $1.17β$2.71; today's close sits at 25% of that range, 42.4% below the 52-week high.
IPHA latest news & SEC filings
Every SEC filing by or about IPHA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 17, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 10, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 2, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 19, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 14, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 10, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 23, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 21, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 22, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade IPHA
- How much it moves: over the last 20 sessions the average daily move was 3.02% (largest 9.5%). That is a volatile stock.
- Liquidity: about 42.85K shares (β$61.28K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.43 vs a range of $1.17β$2.71 (17% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 17, 2026; 6-K Sep 17, 2026; 6-K Sep 17, 2026.
- Listing: Nasdaq Β· industry: Biological Products, (No Diagnostic Substances).
IPHA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.53 | 1.53 | 1.43 | 1.43 | 8.03K |
| Oct 15, 2026 | 1.47 | 1.58 | 1.46 | 1.48 | 7.20K |
| Oct 14, 2026 | 1.44 | 1.47 | 1.42 | 1.43 | 9.30K |
| Oct 13, 2026 | 1.47 | 1.48 | 1.45 | 1.47 | 5.60K |
| Oct 12, 2026 | 1.48 | 1.53 | 1.46 | 1.48 | 33.80K |
| Oct 9, 2026 | 1.49 | 1.68 | 1.49 | 1.62 | 46.90K |
| Oct 8, 2026 | 1.50 | 1.54 | 1.47 | 1.48 | 18.40K |
| Oct 7, 2026 | 1.54 | 1.55 | 1.50 | 1.52 | 13.80K |
| Oct 6, 2026 | 1.58 | 1.65 | 1.53 | 1.59 | 133.70K |
| Oct 5, 2026 | 1.54 | 1.69 | 1.53 | 1.58 | 106.90K |
| Oct 2, 2026 | 1.56 | 1.69 | 1.53 | 1.56 | 92.70K |
| Oct 1, 2026 | 1.60 | 1.67 | 1.58 | 1.59 | 63.90K |
| Sep 30, 2026 | 1.61 | 1.78 | 1.61 | 1.63 | 37.80K |
| Sep 29, 2026 | 1.63 | 1.66 | 1.59 | 1.60 | 31.80K |
| Sep 28, 2026 | 1.71 | 1.79 | 1.66 | 1.70 | 42.10K |
| Sep 25, 2026 | 1.67 | 1.70 | 1.61 | 1.70 | 31.00K |
| Sep 24, 2026 | 1.72 | 1.73 | 1.69 | 1.70 | 17.70K |
| Sep 23, 2026 | 1.81 | 1.81 | 1.76 | 1.76 | 23.70K |
| Sep 22, 2026 | 1.84 | 1.84 | 1.77 | 1.80 | 55.70K |
| Sep 21, 2026 | 1.86 | 1.86 | 1.79 | 1.86 | 77.00K |
About Innate Pharma SA
Innate Pharma SA (IPHA) is listed on the Nasdaq and classified by the SEC under βBiological Products, (No Diagnostic Substances)β. Its business address is in MARSEILLE. State of incorporation: France. Fiscal year ends December 31. SEC CIK 1598599.
IPHA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
IPHA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
IPHA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IPHA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.